Usana Health Sciences (USNA) Cash from Investing Activities (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Cash from Investing Activities data on file, last reported at -$2.6 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 32.98% year-over-year to -$2.6 million in Q2 2026; TTM through Apr 2026 was -$8.8 million, a 95.84% increase from a year earlier, with the FY2026 full-year figure at -$10.1 million, up 95.25% from the prior year.
• Cash from Investing Activities for Q2 2026 stood at -$2.6 million, down from $1.1 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for USNA reached as high as $1.1 million in Q1 2026 and fell as low as -$205.1 million in Q4 2024.
• Historically, Cash from Investing Activities has averaged -$14.0 million across 5 years, with a median of -$3.2 million in 2022.
• Across the five-year window, Cash from Investing Activities jumped 104.81% in 2023 and slumped 2701.67% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at -$3.3 million in 2022, then tumbled by 123.1% to -$7.3 million in 2023, then slumped by 2701.67% to -$205.1 million in 2024, then surged by 98.44% to -$3.2 million in 2025, then grew by 18.79% to -$2.6 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.6 million in Q2 2026, $1.1 million in Q1 2026, and -$3.2 million in Q3 2025.